M. Briones et al., “The Preparation, Characterization, and Evaluation of Cationic Microparticles for DNA Vaccine Delivery,” Pharmaceutical Research, vol. 18, No. 5, 2001, pp. 709-712. |
RK Gupta et al., “Poly (lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines,” Advanced Drug Delivery Review 32 (1998), pp. 226-246. |
Manmohan Singh, et al., “The preparation and characterization of polymeric antigen delivery systems for oral administration,” Advanced Drug Delivery Reviews 34 (1998) 285-304. |
KS Denis-Mize et al., “Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells,” Gene Therapy 2000, pp. 2105-2112. |
J. Kazzaz et al., “Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1,” Journal of Controlled Release 67 (2000), pp. 347-356. |
Manmohan Singh et al., “Cationic microparticles: A potent delivery system for DNA vaccines,” Proceedings of the National Academy of Science, Jan. 18, 2000, vol. 97, No. 2, pp. 811-816. |
D.T. O'Hagan et al., “Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles,” Vaccine, vol. 11, Issue 9, 1993, pp. 965-969. |
Hayley Jefferey et al., “The Preparation and Characterization of Poly(lactide-co-glycolide) Microparticles. II. The Entrapment of a Model Protein Using a (Water-in-Oil)-in-Water Emulsion Solvent Evaporation Technique,” Pharmaceutical Research, vol. 10, No. 3, 1993, pp. 362-368. |
Yasuaki Ogawa et al., “A New Technique to Efficiently Entrap Leuprolide Acetate into Microcapsules of Polylactic Acid or Copoly (Lactic/Glycolic) Acid,” Chem. Pharm. Bull., vol. 36, 1988, pp. 1095-1103. |
John M. Polo et al., “Stable alphavirus packaging cell lines for Sindbis virus-and Semliki Forest virus-derived vectors,” Proceedings of the National Academy of Science, vol. 96, Apr. 1999, pp. 4598-4603. |
Barbara S. Chapman, “Effect of intron A from human cytoegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells,” Nucleic Acids Research, vol. 19, No. 14, pp. 3979-3986. |
A.G.A. Coombes et al., “Single dose, polymeric, microparticle-based vaccines: the influence of fomrulation conditions on the magnitude and duration of the immune response to a protein antigen,” Vaccine, vol. 14, No. 15, 1996, pp. 1429-1438. |
J.D. Duncan et al., “Poly(lactide-co-glycolide) Microencapsulation of Vaccines for Mucosal Immunization,” Mucosal Vaccines, 1996, pp. 159-173. |
J. Eldridge et al., “New Advances in Vaccine Delivery Systems,” Seminars in Hematology, vol. 30, No. 4 Suppl. 4, Oct. 1993, pp. 16-25. |
D. Higgins et al., “MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice,” Vaccine, vol. 14, No. 6, 1996, pp. 478-484. |
Y. Men et al., “Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres,” Vaccine, vol. 15, No. 12/13, 1997, pp. 1405-1412. |
A. Moore, et al., “Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-speicif CD8+ cytotoxic T lymphocytes and CD4+ TH1 cells,” Vaccine, vol. 13, No. 18, 1995, pp. 1741-1995. |
R. Nakoaka et al., “Enhanced antibody production through sustained antigen release from biodegradable granules,” Journal of Controlled Release 37 (1995), pp. 215-224. |
D. O'Hagan et al., “Biodegradable microparticles for oral immunization,” Vaccine, vol. 11, 1993, pp. 149-154. |
D. O'Hagan et al., “Long-term antibody responses in mice following subcutaneous immunixation with ovalbumin entrapped in biodegradable microparticles,” Vaccine, vol. 11, 1993, pp., 965-969. |
H. Sah et al., “Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant,” Journal of Controlled Release 35 (1995), pp. 137-144. |
H.M. Vordermeier et al., “Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculos 38 kDa protein entrapped in biodegradable PLG microparticles,” Vaccine, vol. 13, No. 16, 1995, pp. 1576-1582. |
M.F. Powell et al., “Vaccine Design: The Subunit and Adjuvant Approach,” Plenum Press, NY, 1995, p. 183. |
J. Eldridge et al., “Biodegradable and Biocompatible Poly(DL-Lactide-Co-Glycolide) Microspheres as an Adjuvant for Straphylococcal Enterotoxin B Toxoid Which Enhances the Level of Toxin-Neutralizing Antibodies,” Infection and Immunity, vol. 59, No. 9, Sep. 1991, pp. 2978-2986. |
J. Kazzaz et al., “Induction of cytotoxic T-lymphocyte activity in mice with HIV p24 gag protein adsorbed to the surface of poly(lactide-co-glycolide) microparticles,” Proceed. Int'l. Symp. Control. Rel. Bioact. Mater., 26 (1999), Controlled Release Society., pp. 104-105. |